EquityBee
Fund employee stock options in startups
Pros & Cons
Pros
- Unique access via employee options
- Pre-IPO upside
Cons
- Complex instrument
- Accredited only
- Illiquid
- 20% profit share
The Brief
MoneyMade Verdict
EquityBee is the most accessible way for accredited investors to buy into VC-backed startups before an IPO — but you're betting on companies that may never exit, and your money could be locked up for years.
EquityBee is a Silicon Valley-based platform founded in 2018 that solves a specific problem in the pre-IPO startup world: employees at private companies often have valuable stock options they can't afford to exercise, because doing so requires paying the strike price plus taxes — often totaling tens or hundreds of thousands of dollars — on equity that may or may not ever become liquid. EquityBee connects those employees with accredited investors who provide the capital needed to exercise the options, in exchange for a pre-negotiated share of the future value when the company IPOs, gets acquired, or the employee sells on the secondary market. The platform has raised over $70 million in venture funding from investors including ICONIQ Capital and has facilitated deals in 1,000+ private companies since inception.
From the investor's perspective, EquityBee offers a novel way to gain exposure to late-stage private companies — including names like SpaceX, Stripe, Databricks, and others — with minimums typically starting at $10,000 per deal. Each deal is a bilateral agreement between the investor and a specific employee at a specific company, structured as a loan-plus-equity-share contract that pays out only upon a liquidity event. Investors typically receive 40%–50% of the eventual profit on the exercised shares, with the employee keeping the remainder and using EquityBee's capital to turn an otherwise-unaffordable opportunity into real equity. The platform charges a 5% fee to employees on funded deals and does not charge fees to investors directly — investors pay a spread built into the deal terms.
Head-to-Head
| Platform | Min | Target Return | Annual Fee | Liquidity | Accredited |
|---|---|---|---|---|---|
| — | Option-like returns | 20% profit share | 3–7 years | Yes | |
| $25K | 6–8% | 1.5% annual management | 5–15 years | Yes | |
| $10K | VC-style returns | 2% management + 20% carry | 5–10 years | Yes | |
| $100 | 8–12% | 1% annual fee | 5–25 years | No | |
| $100 | 4–8% | Varies by offering | 5–20 years | No |
Also in Private Companies
AgFunder
commodities
Min N/ALearn more →AngelList
private companies
Min $1KLearn more →Arta Finance
stocks
Min N/ALearn more →Bioverge
private companies
Min N/ALearn more →Carta
private companies
Min N/ALearn more →Commonwealth
stocks
Min N/ALearn more →